Jack O'Meara

Jack O'Meara is a serial biotech entrepreneur and the CEO & Co-founder of Aerska, a biotechnology startup focused on developing innovative RNA interference (RNAi) medicines for treating diseases of the brain. With a strong background in biotechnology and a passion for advancing genetic medicine, Jack is dedicated to overcoming the challenges of delivering genetic therapies across the blood-brain barrier. Under his leadership, Aerska has successfully launched with $21 million in financing, positioning itself as a leader in the field of brain disease therapeutics.